Monitoring Circulating γδ T Cells in Cancer Patients to Optimize γδ T Cell-Based Immunotherapy

The success of γδ T cell-based immunotherapy, where the cytotoxic activity of circulating γδ T lymphocytes is activated by nitrogen-containing bisphosphonates (n-BP), or possibly by bispecific antibodies or the combination of both, requires a profound knowledge of patients’ γδ T cells. A possible in...

Descripción completa

Detalles Bibliográficos
Autores principales: Oberg, Hans-Heinrich, Kellner, Christian, Peipp, Matthias, Sebens, Susanne, Adam-Klages, Sabine, Gramatzki, Martin, Kabelitz, Dieter, Wesch, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269191/
https://www.ncbi.nlm.nih.gov/pubmed/25566256
http://dx.doi.org/10.3389/fimmu.2014.00643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269191/
https://www.ncbi.nlm.nih.gov/pubmed/25566256
http://dx.doi.org/10.3389/fimmu.2014.00643

Ejemplares similares